Results 81 to 90 of about 682 (125)

An IRES-like cis-acting element located within the EV-A71 coding region drives translation independent of the 5'-IRES and modulates viral fitness through regulated binding of viral RNA to 3D polymerase. [PDF]

J Virol
Xing Y, Liu Q, Fu M, Zheng H, Zhao T, Chen X, Cai X, Long J-E.   +7 more
europepmc   +1 more source

Editorial: Toxicity mechanisms, exposure, toxicokinetic and risk assessment aspects of metals, toxic for animals and humans, volume III. [PDF]

Front Pharmacol
Zhu Y, El Demerdash FM, Yang X, Machado MM, Boye A, Sun X.   +5 more
europepmc   +1 more source

Factors Influencing COVID-19 Viral Clearance: Implications for Vaccination and Antiviral Therapy. [PDF]

Infect Drug Resist
Zeng J, Xu H, Luo S, Zhou X, Li X, Zeng Y, Wang Y, Jiang H, Lin C, Zheng C, Ruan J, Yu W, Yao J, Zhao J.   +13 more
europepmc   +1 more source

Composite outcome of oral azvudine vs. nirmatrelvir-ritonavir in COVID-19 patients: a retrospective cohort study. [PDF]

Front Pharmacol
Chen J, Liu Z, Liu R, Su C, Yang Y, Wang Z.   +5 more
europepmc   +1 more source

Editorial: Emerging concepts for respiratory viruses after the pandemic. [PDF]

Front Cell Infect Microbiol
Dimopoulou D, Skevaki C, Can F, Morfin-Sherpa F, Fragkou PC.   +4 more
europepmc   +1 more source

Characteristics of patients with non-severe infections of different SARS-CoV-2 omicron subvariants in China. [PDF]

Front Med (Lausanne)
Yuan W, Liu Y, Zhan H, Wei F, Zhang Q, Gao H, Yan H, Huang T, Li Y, Dai E.   +9 more
europepmc   +1 more source

Efficacy of Azvudine Therapy in Patients with Severe and Non-Severe COVID-19: A Propensity Score-Matched Analysis. [PDF]

Infect Drug Resist
Zhang S, Tan S, Yang B, Wu Y, Yuan G, Chen F, Liu L.   +6 more
europepmc   +1 more source

Construction of Minigenome Replicon of Nipah Virus and Investigation of Biological Activity. [PDF]

Viruses
Wang F, Chen R, Zhong J, Zhou A, Peng R, Xue B, Zhou Y, Tang J, Chen X, Yang Q.   +9 more
europepmc   +1 more source

Effectiveness and safety of azvudine versus nirmatrelvir-ritonavir in adult patients infected with COVID-19 omicron strains: a retrospective study in Beijing. [PDF]

Sci Rep
Xie H, Wang Y, Xu Y, Wang L, Fan J, Pan S, Shi C, Liu X, Gao X, Guo X, Yu S, Liu J, Zhang D, Yang Y, Zhang H, Wang J, Wu A, Liu X, Liu J, Zhu H, Zhou X, Tian X, Wang M.   +22 more
europepmc   +1 more source

Immunophenotyping characteristics and clinical outcome of COVID-19 patients treated with azvudine during the Omicron surge. [PDF]

Front Immunol
Qiu M, Song X, Zhang Q, Zou S, Pang L, Nian X.   +5 more
europepmc   +1 more source